Machine learning algorithms for detection of visuomotor neural control differences in individuals with PASC and ME.

Evidence Atlas

Ahuja, Harit, Badhwar, Smriti, Edgell, Heather et al. · Frontiers in human neuroscience · 2024 · DOI

Quick Summary

Researchers developed a new method using a simple headband that reads brain activity (EEG) to help identify people with long COVID or ME/CFS. The study used artificial intelligence to analyze brain patterns, and when trained on computer-generated synthetic data, the system was able to correctly identify these conditions 93% of the time. This approach could eventually help doctors diagnose and monitor these conditions more quickly.

Why It Matters

Early, objective detection methods for ME/CFS and PASC are critically needed, as both conditions currently lack biomarkers and rely on clinical diagnosis. This research suggests that non-invasive, wearable EEG monitoring combined with AI could enable faster identification and facilitate longitudinal monitoring of intervention effectiveness, potentially improving access to care.

Observed Findings

CNN-LSTM model achieved 83% accuracy in distinguishing PASC/ME from controls using real EEG spectrograms
Synthetic spectrograms generated by WGANs improved model performance to 93% average accuracy
Deep learning models (CONVLSTM, CNN-LSTM, Bi-LSTM) generally outperformed traditional machine learning approaches
A four-channel EEG headband was sufficient to collect discriminative visuomotor neural control signals

Inferred Conclusions

Wearable EEG technology combined with machine learning is feasible for detecting PASC and ME
Data augmentation using GANs can overcome dataset limitations while addressing privacy concerns
The approach has potential clinical applications for patient evaluation and monitoring of intervention response
Neural control differences detectable via EEG may represent a biomarker for these conditions

Remaining Questions

What was the actual sample size and demographic composition of the study cohort, and how do results vary across different populations?
Has the model been validated on completely independent prospective cohorts, and what is the clinical specificity and sensitivity in real-world settings?

What This Study Does Not Prove

This study does not establish that EEG differences are mechanistic causes of PASC/ME symptoms—only that detectable neural control differences exist. The high accuracy with synthetic data, while encouraging, does not guarantee real-world clinical performance without independent validation. The study does not clarify what specific neurological processes the EEG patterns represent or whether findings generalize across ethnically, demographically, and geographically diverse populations.

Metadata

DOI: 10.3389/fnhum.2024.1359162
PMID: 38638805
Review status: Editor reviewed
Evidence level: Early hypothesis, preprint, editorial, or weak support
Last updated: 12 April 2026

About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →

Evidence Atlas

Machine learning algorithms for detection of visuomotor neural control differences in individuals with PASC and ME.

Quick Summary

Why It Matters

Observed Findings

Inferred Conclusions

Remaining Questions

What This Study Does Not Prove

Topics

Tags

Metadata

Explore further